Openwater Secures $100M to Advance Hospital-Grade Medical Technology

Openwater has announced an acceleration in its plans to bring its hospital-grade technology platform to the commercial market. The platform integrates semiconductor physics, light, and sound to diagnose and treat diseases at the cellular level.  Mary Lou Jepsen, a brain tumor survivor and former executive at Google X, Meta, and 'One Laptop Per Child', founded the company. Openwater has raised $100 million from new and existing investors including Plum Alley Ventures, Khosla Ventures, BOLD Capital Partners, Esther Dyson, and Peter Gabriel. 

The healthcare platform combines high-resolution infrared imaging, precision-tuned ultrasound, and targeted electromagnetic fields, allowing unprecedented visualization, monitoring, and treatment of biological issues. Clinical studies have shown promising results, including shrinking glioblastoma tumors in mice and treating severe depression in humans. Openwater's open-source approach aims to accelerate medical innovation by reducing regulatory time and costs. The company leverages consumer electronics manufacturing processes to make advanced medical capabilities more accessible and affordable globally. Read the full press release here.